FALLON ZIELENSKI: Open Payments
NPI 1871101501 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 84 payments from 21 companies in 2025. Trend: 2023 $477 · 2024 $1,498 · 2025 $1,946
Food & beverage: $1,946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $422 |
| Novo Nordisk Inc | 9 | $315 |
| GlaxoSmithKline, LLC. | 11 | $288 |
| Abbott Laboratories | 4 | $191 |
| Lilly USA, LLC | 7 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Amgen Inc. | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $40 |
Products named: SHINGRIX, FREESTYLE LIBRE 3, VRAYLAR, Ozempic, QULIPTA, Wegovy, JARDIANCE, UBRELVY.
Industry payments across NY — which companies pay providers there.
